Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28612856 | 0.97 | LMNA (0.35) | LMNACA2 | |
| SCHEMBL3776532 | 0.97 | LMNA (0.35) | LMNACA2 | |
| SCHEMBL810661 | 0.97 | LMNA (0.35) | LMNACA2 | |
| SCHEMBL3778734 | 0.97 | LMNA (0.35) | LMNACA2 | |
| SCHEMBL811215 | 0.97 | LMNA (0.35) | LMNACA2 | |
| SCHEMBL3770995 | 0.97 | LMNA (0.35) | LMNACA2 | |
| SCHEMBL5519977 | 0.95 | LMNA (0.30) | LMNA | |
| SCHEMBL4806756 | 0.89 | — | — | |
| SCHEMBL4806917 | 0.89 | — | — | |
| SCHEMBL13738326 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9102872-B2 | Device material for hole injection transport layer, ink for forming hole injection transport layer, device comprising hole injection transport layer, and method for producing the device | DAI NIPPON PRINTING CO., LTD. (JP) | 2015-08-11 | — | — | US | disclosed |
| EP-2461388-A1 | DEVICE MATERIAL FOR HOLE INJECTION/TRANSPORT LAYER, INK FOR FORMING HOLE INJECTION/TRANSPORT LAYER, DEVICE HAVING HOLE INJECTION/TRANSPORT LAYER, AND METHOD FOR MANUFACTURING SAME | Dai Nippon Printing Co., Ltd. (JP) | 2012-06-06 | — | — | EP | disclosed |
| US-20120119200-A1 | DEVICE MATERIAL FOR HOLE INJECTION TRANSPORT LAYER, INK FOR FORMING HOLE INJECTION TRANSPORT LAYER, DEVICE COMPRISING HOLE INJECTION TRANSPORT LAYER, AND METHOD FOR PRODUCING THE DEVICE | DAI NIPPON PRINTING CO., LTD. (JP) | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120119200-A1 | DEVICE MATERIAL FOR HOLE INJECTION TRANSPORT LAYER, INK FOR FORMING HOLE INJECTION TRANSPORT LAYER, DEVICE COMPRISING HOLE INJECTION TRANSPORT LAYER, AND METHOD FOR PRODUCING THE DEVICE | NPC1L1, SLCO2B1, SLCO4C1 | LMNA 3065/4885CA2 4718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.